TP53 and plasma cell leukemia: Furthermore, it has been recently reported that biallelic inactivation of TP53 is more common in aggressive plasma cell neoplasms, and is frequently seen at relapse leading to rapid progression to plasma cell leukemia and/or extramedullary disease [16,49].